Previous 10 | Next 10 |
10x Genomics Launches BEAM to Improve and Streamline Antibody and T-Cell Receptor Discovery PR Newswire Barcode Enabled Antigen Mapping (BEAM) screens multiple antigens against thousands of B- or T-cells to identify novel and rare antigen-specific repertoires ...
10x Genomics ( NASDAQ: TXG ) stock rose ~17% on Thursday after Q3 results beat estimates and the company maintained its FY22 revenue outlook. Net loss per share widened to -$0.37, compared to -0.15 in Q3 2021. Meanwhile, revenue grew +4.6% Y/Y to $131.07M....
10x Genomics, Inc. (TXG) Q3 2022 Earnings Conference Call November 02, 2022 04:30 PM ET Company Participants Cassie Corneau - Head, Investor Relations & Strategic Finance Serge Saxonov - Chief Executive Officer & Co-Founder Justin McAnear - Chief Financia...
10x Genomics press release ( NASDAQ: TXG ): Q3 GAAP EPS of -$0.37 beats by $0.11 . Revenue of $131.07M (+4.6% Y/Y) beats by $1.94M . Cash and cash equivalents and marketable securities were $452.4 million as of September 30, 2022. 2022 Guidance: ...
10x Genomics Reports Third Quarter 2022 Financial Results PR Newswire PLEASANTON, Calif. , Nov. 2, 2022 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG) today reported financial results for the third quarter ended September 30, 2022. ...
10x Genomics to Host Investor Day on December 8, 2022 PR Newswire PLEASANTON, Calif. , Oct. 31, 2022 /PRNewswire/ -- 10x Genomics (Nasdaq: TXG) today announced it will host an Investor Day on December 8, 2022 at the company's headquarters in Pleasanton, CA ...
Summary Baillie Gifford’s 13F portfolio value decreased from ~$97.51B to ~$96.99B this quarter. They increased Shopify, Roblox, Zoom Video, and Twilio while reducing Albemarle Corporation and Li Auto ADR. The top three positions are Tesla Motors, Moderna, and MercadoLib...
Summary ARK Invest’s 13F portfolio value decreased from $16.91B to $14.35B this quarter. UiPath, Ginkgo Bioworks, and NVIDIA were increased while decreasing Spotify, Ionis Pharma, CRISPR Therapeutics, and Coinbase Global. The top three positions are Tesla Inc., Zoom Vid...
10x Genomics to Report Third Quarter Financial Results on November 2, 2022 PR Newswire PLEASANTON, Calif. , Oct. 12, 2022 /PRNewswire/ -- 10x Genomics (Nasdaq: TXG) today announced it will report financial results for the third quarter 2022 after mar...
Summary The Health Care sector and Biotech niche have both been interesting sources of relative market strength in recent months; one defensive, one more risk-on. 10x Genomics was a massive winner around the Covid-19 pandemic, but an improving health situation around the world pos...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 06:00:09 ET Kyle Mikson from Canaccord Genuity issued a price target of $32.00 for TXG on 2024-07-23 05:09:00. The adjusted price target was set to $32.00. At the time of the announcement, TXG was trading at $18.11. The overall price target consensus is at $24...
10x Genomics to Report Second Quarter 2024 Financial Results on August 8, 2024 PR Newswire PLEASANTON, Calif. , July 12, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it will report fi...
A look at the top 10 most actives in the United States Kazia Therapeutics Limited (KZIA) rose 248.0% to $0.6682 on volume of 430,252,408 shares Maxeon Solar Technologies Ltd. (MAXN) fell 15.0% to $0.2108 on volume of 237,403,092 shares NVIDIA Corporation (NVDA) rose 2.7% to $134.91 on vol...